Zinc and human health: an update CT Chasapis, AC Loutsidou, CA Spiliopoulou, ME Stefanidou Archives of toxicology 86, 521-534, 2012 | 1239 | 2012 |
Recent aspects of the effects of zinc on human health CT Chasapis, PSA Ntoupa, CA Spiliopoulou, ME Stefanidou Archives of toxicology 94, 1443-1460, 2020 | 560 | 2020 |
Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE) A Asimakopoulou, P Panopoulos, CT Chasapis, C Coletta, Z Zhou, ... British journal of pharmacology 169 (4), 922-932, 2013 | 424 | 2013 |
Environmental barium: potential exposure and health-hazards M Peana, S Medici, M Dadar, MA Zoroddu, A Pelucelli, CT Chasapis, ... Archives of toxicology 95 (8), 2605-2612, 2021 | 128 | 2021 |
Biological effects of human exposure to environmental cadmium M Peana, A Pelucelli, CT Chasapis, SP Perlepes, V Bekiari, S Medici, ... Biomolecules 13 (1), 36, 2022 | 112 | 2022 |
A NMR study of the interaction of a three-domain construct of ATP7A with copper (I) and copper (I)-HAH1: the interplay of domains L Banci, I Bertini, F Cantini, CT Chasapis, N Hadjiliadis, A Rosato Journal of Biological Chemistry 280 (46), 38259-38263, 2005 | 80 | 2005 |
RING finger E3 ubiquitin ligases: structure and drug discovery CT Chasapis, GA Spyroulias Current pharmaceutical design 15 (31), 3716-3731, 2009 | 78 | 2009 |
Thioredoxin reductase as a pharmacological target G Bjørklund, L Zou, J Wang, CT Chasapis, M Peana Pharmacological research 174, 105854, 2021 | 74 | 2021 |
An NMR study of the interaction between the human copper (I) chaperone and the second and fifth metal‐binding domains of the Menkes protein L Banci, I Bertini, S Ciofi‐Baffoni, CT Chasapis, N Hadjiliadis, A Rosato The FEBS journal 272 (3), 865-871, 2005 | 71 | 2005 |
Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS … G Lagoumintzis, CT Chasapis, N Alexandris, D Kouretas, S Tzartos, ... Food and Chemical Toxicology 149, 112009, 2021 | 60 | 2021 |
Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions N Alexandris, G Lagoumintzis, CT Chasapis, DD Leonidas, ... Toxicology reports 8, 73-83, 2021 | 54 | 2021 |
Organotin(IV) Derivatives of L‐Cysteine and their in vitro Anti‐Tumor Properties CT Chasapis, SK Hadjikakou, A Garoufis, N Hadjiliads, T Bakas, ... Bioinorganic Chemistry and Applications 2 (1-2), 43-54, 2004 | 38 | 2004 |
NMR‐based insights into the conformational and interaction properties of Arkadia RING‐H2 E3 Ub ligase CT Chasapis, NG Kandias, V Episkopou, D Bentrop, GA Spyroulias Proteins: Structure, Function, and Bioinformatics 80 (5), 1484-1489, 2012 | 35 | 2012 |
Natural dietary compounds in the treatment of arsenic toxicity G Bjørklund, MS Rahaman, M Shanaida, R Lysiuk, P Oliynyk, L Lenchyk, ... Molecules 27 (15), 4871, 2022 | 32 | 2022 |
Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2 H Ridgway, GJ Moore, T Mavromoustakos, S Tsiodras, I Ligielli, ... Computational and structural biotechnology journal 20, 2091-2111, 2022 | 32 | 2022 |
Identification of the zinc, copper and cadmium metalloproteome of the protozoon Tetrahymena thermophila by systematic bioinformatics CT Chasapis, C Andreini, AK Georgiopolou, ME Stefanidou, ... Archives of microbiology 199, 1141-1149, 2017 | 32 | 2017 |
Interaction of the two soluble metal-binding domains of yeast Ccc2 with copper (I)–Atx1 L Banci, I Bertini, CT Chasapis, A Rosato, L Tenori Biochemical and biophysical research communications 364 (3), 645-649, 2007 | 31 | 2007 |
Multifunctional role of zinc in human health: an update DP Kiouri, E Tsoupra, M Peana, SP Perlepes, ME Stefanidou, ... EXCLI journal 22, 809, 2023 | 30 | 2023 |
The role of the thioredoxin system in brain diseases G Bjørklund, L Zou, M Peana, CT Chasapis, T Hangan, J Lu, M Maes Antioxidants 11 (11), 2161, 2022 | 30 | 2022 |
Understanding the driving forces that trigger mutations in SARS-CoV-2: mutational energetics and the role of arginine blockers in COVID-19 therapy H Ridgway, CT Chasapis, K Kelaidonis, I Ligielli, GJ Moore, LK Gadanec, ... Viruses 14 (5), 1029, 2022 | 30 | 2022 |